Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Rev Esp Enferm Dig ; 115(2): 89-90, 2023 02.
Artigo em Inglês | MEDLINE | ID: mdl-35315681

RESUMO

Liver abscesses are an entity that sets out a diagnostic challenge with a severe clinical course and non-negligible mortality. Their origin is usually bacterial (>80%), parasitic, mixed or, more rarely, fungal. We present the case report of a 45-year-old man, native of Ghana, with no relevant medical-surgical history, was admitted for septic shock with multiple organ dysfuntion syndrome. Complementary imaging tests revealed a liver abscess in segments IV and VII measuring 60x45x54 mm, so antibiotic treatment with piperacillin-tazobactam was started and a pigtail drainage was placed. In blood cultures, the microorganism parvimonas micra (anaerobic gram-positive cocci) was isolated with high degree of sensitivity rates to penicillin, clindamycin and metronidazole. Treatment was de-escalated to clindamycin until completing 4 weeks of intravenous treatment. Control CT showed a decrease in the size of the abscess and pigtail drainage was removed.


Assuntos
Clindamicina , Abscesso Hepático , Masculino , Humanos , Pessoa de Meia-Idade , Clindamicina/uso terapêutico , Antibacterianos/uso terapêutico , Firmicutes , Abscesso Hepático/diagnóstico por imagem , Abscesso Hepático/tratamento farmacológico
2.
Rev Esp Enferm Dig ; 113(8): 591-596, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33371701

RESUMO

INTRODUCTION: there is a rising number of patients receiving antiplatelet and anticoagulation therapy who require endoscopic retrograde cholangiopancreatography (ERCP), probably due to the increased morbidity of older patients. Considering the increasing use of direct oral anticoagulants (DOACs), this study aimed to determine the influence of these factors on the possibility of hemorrhage after ERCP in our center. MATERIAL AND METHODS: data were collected from all the examinations carried out in 2017 and 2018, which included 797 examinations on 588 patients. Collected data included personal history of the patients, results of the test and follow-up. RESULTS: the percentage of post-ERCP bleeding was 4.6 % (n = 37). With regard to the severity, the bleeding was mild in 21.6 % (n = 8) of the cases, moderate in 59.5 % (n = 22) and severe in 18.9 % (n = 7). Previous cardiopathy antiplatelet therapy, anticoagulation therapy, treatment with DOACs, having a pancreatic stent and lithiasis removal doubled the risk of bleeding after ERCP. Having a sphincterotomy increased the risk by over five-fold. CONCLUSION: according to the multivariate analysis, a statistically significant increase of bleeding among patients treated with DOACs was observed compared to patients who received anticoagulation with acenocoumarol or low-molecular-weight heparins (LMWH).


Assuntos
Colangiopancreatografia Retrógrada Endoscópica , Heparina de Baixo Peso Molecular , Anticoagulantes/efeitos adversos , Colangiopancreatografia Retrógrada Endoscópica/efeitos adversos , Hemorragia , Humanos , Estudos Retrospectivos , Fatores de Risco , Stents
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA